Evidence map›Paper›PMID 41306413›Full record

ArticleJournal of diabetes and metabolic disorders2025

Therapeutic potential of pectin from various sources against diabetes mellitus in rats: AKT/PI3K/GSK-3β/CREB signaling pathways, inflammation, oxidative stress and genotoxicity crosstalk.

Yomna R Ahmed, Rehab M Abdel-Megeed, Samar M Gooda, Nahla N Kamel, Gehan F Abdel Raoof, Entesar E S Hassan, Ayman A Farghaly, Mohamed A El-Saied, Nagy S El-Rigal, Maha Z Rizk and 1 more

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yomna R AhmedDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Rehab M Abdel-MegeedDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Samar M GoodaDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Nahla N KamelDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Gehan F Abdel RaoofPharmacognosy Department, National Research Centre, Dokki, Cairo, Egypt.
Entesar E S HassanDepartment of Genetics and Cytology, National Research Centre, Dokki, Cairo, Egypt.
Ayman A FarghalyDepartment of Genetics and Cytology, National Research Centre, Dokki, Cairo, Egypt.
Mohamed A El-SaiedDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Nagy S El-RigalDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Maha Z RizkDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.
Manal A HamedDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, Egypt.ORCID 0000-0003-3643-5842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus type 2 (DMT2) is a chronic metabolic disorder caused by a disruption or resistance in insulin secretion. AKT /PI3K, GSK-3β and CREB signaling pathways influence insulin sensitivity and glucose metabolism. Purpose: This study aimed to compare the therapeutic impact of pectin extracted from different sources (lemon, orange and grapefruit peels) against diabetic rats. Methods: Fourier transform infrared spectroscopy (FT-RI) and Proton Nuclear Magnetic Resonance ( Results: The FT-IR and Conclusion: Pectin extracted from lemon, orange and grapefruit peels showed a promising therapeutic impact against DMT2. High degree of esterification in lemon pectin may explore its potent effect Graphical Abstract:

Indexed as

DiabetesFT-RIGenetic aberrationsOxidative stressPectinSignaling pathways

Identifiers

PMID41306413
PMCPMC12644379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.